Analyst Expectations for MorphoSys's Future
Portfolio Pulse from Benzinga Insights
MorphoSys (NASDAQ:MOR) has received 5 analyst ratings in the last quarter, with 4 being somewhat bullish and 1 indifferent. The average price target is $11.29, representing an implied upside from the current price of $9.35. This target has increased by 37.01% from the previous target of $8.24. Analysts rate stocks typically once a quarter and provide insights on financial performance and forecasts.
December 15, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MorphoSys has a positive outlook from analysts with 4 somewhat bullish ratings and an average price target of $11.29, suggesting a potential upside from the current price of $9.35.
The positive sentiment from analysts, with 4 out of 5 showing a somewhat bullish stance and none bearish, combined with a significant increase in the average price target, suggests a strong potential for stock price appreciation in the short term. The lack of bearish ratings and the substantial 37.01% increase in the price target from the previous average are likely to be viewed favorably by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100